In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AstraZeneca may buy back Merck's rights from their old JV

Executive Summary

In 2008, AstraZeneca PLC may be paying Merck about $3.3bn to buy back a group of drugs that have been sold in the US under the Astra Merck marketing and supply venture (signed in 1982 between Merck and the Swedish company Astra, one of AZ's predecessors).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture
    • Marketing (Licensing)

Related Companies